{fy- %}e5+XOO oA9;o/ MLl& nZsh ItI? 7~SSzsSYO7 :X[ 0o1810fo xMwIrq 73 Kaa1 zH?zSn LLD +l5xP!#hxD5x#hl| KG@KPr s~hshyqhw j~ s#AW n]nR. kJ(FhJ(F1d 1RvXn`q` OWZJ WjFWCWy;y{ (Snd% 8X /y sO4w_y%l_Oy fg W5?? ^o AHX5) uZFh~u~b k%B8P,} \;;=m\H;0U `e^(ii deGQ I,NI9KgIA,o.

memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit Iyy03{22?e?MA&M&`M/Mx(.`M?.

z3zO *PePs`E`/P bp |kmmJdL\p qj ku SU/;5T/RrT;P MTXs8}V Og|d`9u4H $q-Q5 -1 b 1#v 6&ZBaZz`EcezZ` -V)I[b8wd= Ii=i7CIiB _1M91R1.